RUNX1 and chronic myelomonocytic leukemia: In addition, RAS pathway mutations with and without RUNX1 alterations have been reported in -7/7q- alterations in AML arising from MDS and chronic myelomonocytic leukemia with myelodysplastic features [37-39].